Philip Morris Shares Advance 1% After FDA Authorizes Marketing of Zyn
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday morning. It is up 28% over the past 12 months.
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
Morgan Stanley (NYSE:MS) initiated coverage on shares of Philip Morris International Inc. (NYSE:NYSE:PM) shares, bestowing an Overweight rating and establishing a price target of $140. The move ...
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
Philip Morris was fined $1.2 million over the weekend ... The cautionary example here though is Juul, the high strength e-cigarette brand accused in multiple lawsuits of targeting underage users ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback